Test Code 5265

PassageBio FTD

19 genes

3 weeks (STAT 2 weeks)

Indications

This program is open to patients, who have a suspected clinical or clinical diagnosis of frontotemporal dementia.

Method
Sequencing with CNV PGxome
Specimen(s)

Specimens

Order Options

Platform
OTHER OPTIONS
for pricing.

Marketing blurb

Interpreting genetic test results involves understanding whether a genetic change is positive (indicating a potential health risk), negative, or uncertain in significance. It’s important to discuss these results with a healthcare professional to understand their impact on your patient’s health and any necessary next steps.

Questions? We can help.

Getting support has never been easier. Let us connect you with our specialists that will assist you with anything from understanding products to navigating insurance questions.